Skip to main content
SRPT
NASDAQ Life Sciences

FDA Accepts Sarepta's sNDAs for Amondys 45 and Vyondys 53, Sets Feb 2027 PDUFA Date

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$17.3
Mkt Cap
$1.797B
52W Low
$10.415
52W High
$25.32
52W Position info
66% above low
Off High info
32% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SRPT sits 66% above its 52-week low of $10.415.

Summary

Sarepta Therapeutics announced the FDA's acceptance of Supplemental New Drug Applications (sNDAs) for its Duchenne muscular dystrophy drugs, Amondys 45 and Vyondys 53. This is a positive regulatory development, indicating the FDA will proceed with reviewing the applications. The agency has set a PDUFA target action date of February 28, 2027, for a decision, providing a clear timeline for potential label expansions or other product enhancements.

At the time of this announcement, SRPT was trading at $17.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $10.42 to $25.32. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SRPT - Latest Insights

SRPT
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.93
Real-time Price: $14.19 info
Change: -$3.74 (-21%) info
Market Cap: $1.52B info
SRPT
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $16.65
Real-time Price: $14.19 info
Change: -$2.46 (-15%) info
Market Cap: $1.52B info
SRPT
Nov 05, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $17.57
Real-time Price: $14.19 info
Change: -$3.38 (-19%) info
Market Cap: $1.52B info
SRPT
Sep 30, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $18.64
Real-time Price: $14.19 info
Change: -$4.45 (-24%) info
Market Cap: $1.52B info
SRPT
Sep 23, 2026, 4:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $19.03
Real-time Price: $14.19 info
Change: -$4.84 (-25%) info
Market Cap: $1.52B info